Tratamiento conservador de la osteoartrosis de cadera con toxina botulínica tipo A

1Citations
Citations of this article
116Readers
Mendeley users who have this article in their library.

Abstract

Introduction: Osteoarthritis (OA) of the hip is a low-grade inflammatory disease of multiple etiology that has a limited conservative management and insufficiently explored. The application of botulinum toxin type A (BoNT-A) produces in the applied muscle a temporary, delimitable and reversible flaccid paralysis, which applicated in a strategic way achives to reduce mechanical stress and pain. Objective: To evaluate the effect on pain perception, functionality and rigidity and changes in flexibility, internal and external rotation, before and 90 days after the application of BoNT-A. Methods: Clinical, experimental, longitudinal, open study, with a total of 35 patients and 45 hips treated. BoNT-A of 500 U was applied in iliac, adductor brevis and longus muscles. Results: The Wilcoxon test was used to compare the evaluation scores on days 0-90, observing the decrease in referred pain (p < 0.0001), rigidity (p < 0.002), improved perceived function (p < 0.001) and mobility arcs: Flexion, internal and external rotation (p < 0.0001). Conclusions: The treatment with BoNT-A provides a conservative and safe option for the management of symptoms and physical restraint caused by hip OA.

References Powered by Scopus

Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016

6013Citations
N/AReaders
Get full text

The global burden of hip and knee osteoarthritis: Estimates from the Global Burden of Disease 2010 study

2557Citations
N/AReaders
Get full text

American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee

2314Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Intra-articular botulinum toxin and ozone in osteoarthritis

0Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Durán-Hernández, S., Soto-Rodríguez, J. F., Allen-Bobadilla, J., Durán-Hernández, N., & García-Mosco, P. (2019). Tratamiento conservador de la osteoartrosis de cadera con toxina botulínica tipo A. Gaceta Medica de Mexico, 155, 56–61. https://doi.org/10.24875/GMM.19005151

Readers over time

‘19‘20‘21‘22‘23‘24‘250255075100

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 12

71%

Professor / Associate Prof. 3

18%

Researcher 2

12%

Readers' Discipline

Tooltip

Nursing and Health Professions 20

51%

Medicine and Dentistry 17

44%

Materials Science 1

3%

Pharmacology, Toxicology and Pharmaceut... 1

3%

Save time finding and organizing research with Mendeley

Sign up for free
0